Xuefeng Guo Selected Research

Nonesterified Fatty Acids (NEFA)

1/2020

TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuefeng Guo Research Topics

Disease

9	Neoplasms (Cancer) 11/2023 - 12/2012
5	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 06/2013
2	Pathologic Constriction (Stenosis) 12/2023 - 10/2021
2	Thyroid Neoplasms (Thyroid Cancer) 11/2023 - 12/2012
2	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2014
2	COVID-19 01/2023 - 01/2021
2	Rectal Neoplasms (Rectal Cancer) 10/2022 - 10/2021
2	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2016
2	Inflammation (Inflammations) 01/2022 - 11/2014
2	Endometritis 08/2021 - 11/2020
2	Infections 06/2017 - 01/2009
2	Human Influenza (Influenza) 05/2014 - 09/2011
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 04/2013 - 11/2011
1	Appendicitis 12/2024
1	Papillary Thyroid Cancer 11/2023
1	Adenoma (Adenomas) 01/2023
1	Wounds and Injuries (Trauma) 11/2022
1	Neoplasm Micrometastasis 07/2022
1	Alcoholic Intoxication (Drunkenness) 01/2022
1	Ischemic Stroke 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Infarction (Infarctions) 01/2022
1	Necrosis 01/2022
1	Pain (Aches) 01/2022
1	Stroke (Strokes) 01/2022
1	Proctitis 10/2021
1	Hemorrhage 09/2020
1	Fatty Liver 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Intraoperative Complications 09/2019
1	Anastomotic Leak 09/2019
1	Ileus 09/2019
1	Weight Gain 05/2019
1	Enteritis 11/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2014
1	Carcinoma (Carcinomatosis) 05/2014
1	Hypoxia (Hypoxemia) 05/2014
1	Hypertriglyceridemia 08/2013
1	Abdominal Obesity 08/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2013

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2014
5	Messenger RNA (mRNA)IBA 11/2023 - 05/2014
3	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2009
2	ChemokinesIBA 08/2022 - 04/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	HMGB1 Protein (HMG1)IBA 08/2021 - 11/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2009
2	Small Interfering RNA (siRNA)IBA 10/2014 - 05/2014
2	SiliconIBA 05/2014 - 09/2011
1	Long Noncoding RNAIBA 04/2024
1	Fibronectins (Fibronectin)IBA 11/2023
1	Capsules (Microcapsules)IBA 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	PolymersIBA 11/2022
1	Coloring Agents (Dyes)IBA 10/2022
1	LigandsIBA 08/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Autophagy-Related ProteinsIBA 01/2022
1	Beclin-1IBA 01/2022
1	AcidsIBA 01/2022
1	AldehydesIBA 01/2022
1	EstersIBA 01/2022
1	Free RadicalsIBA 01/2022
1	IronIBA 01/2022
1	TubulinIBA 01/2022
1	IntegrinsIBA 01/2022
1	SynaptophysinIBA 01/2022
1	Vesicular Glutamate Transport Protein 1IBA 01/2022
1	OsteopontinIBA 01/2022
1	EndotoxinsIBA 08/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	VaccinesIBA 01/2021
1	AntibodiesIBA 01/2021
1	LipopolysaccharidesIBA 11/2020
1	gamma-Butyrobetaine DioxygenaseIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	N,N,N-trimethyl-5-aminovaleric acidIBA 01/2020
1	Nonesterified Fatty Acids (NEFA)IBA 01/2020
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 05/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2017
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	CollagenIBA 10/2014
1	CateninsIBA 10/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014
1	OsteocalcinIBA 08/2013
1	CholesterolIBA 08/2013

Therapy/Procedure

2	Therapeutics 12/2024 - 09/2020
2	Neoadjuvant Therapy 10/2022 - 07/2022
2	Semiconductors 04/2013 - 11/2011
1	Colonoscopes 12/2023
1	Nutritional Support (Artificial Feeding) 01/2023
1	Immunotherapy 08/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Stents 07/2022
1	Intravenous Injections 01/2022
1	Conscious Sedation 01/2022
1	Ileostomy 10/2021
1	Endoscopic Hemostasis 09/2020
1	Operative Time 09/2019